Under UVB stimulation, LCs primarily exert their pro-tumor effects by enhancing the epidermal IL-1β, IL-6, IL-23, and NOS2 expression, along with raising the level of the epithelial growth factor IL-22 (66) (Figure 2). The gene discussed is NOS2; the disease is neoplasm.